Cervical Cancers
46
14
20
15
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 46 trials
100.0%
+13.5% vs benchmark
9%
4 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (46)
IDOV-Immune for Advanced Solid Tumors
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
Unidos Contra el VPH
Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer
Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)
GYNecologic Cancer-Related COGnitive Impairment
The Effect of Motivational Interviewing on HPV-DNA Testing
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Toripalimab for High-risk Locally Advanced Cervical Cancer
A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial
Self-sampling for HPV Screening
The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients